Three key considerations for deploying technology to help increase diversity in trials.
Otis Johnson, PhD
Advertisement
Articles by Otis Johnson, PhD
Today, a data-driven approach to feasibility assessment can help ensure that a sponsor’s clinical research plan is designed to enroll the right patients, rely on the right investigators, and take place in the right countries for success.
Advertisement
Latest Updated Articles
Sponsors Ask: Is Our Trial Plan Realistic? Toward a Data-Driven Feasibility AssessmentPublished: December 21st 2017 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
2
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
3
Reframing the IND: From Tactical Requirement to Strategic Opportunity
4
Streamlining Trial Design to Accelerate Data Delivery and Investor Confidence
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
